Enrollment milestone achieved ahead of schedule as Solaris DE drug-eluting continues to gather additional clinical ...
Solaris Endovascular, Inc. announced that the DEScover clinical trial has completed enrollment. According to the comp ...
View source version on businesswire.com: https://www.businesswire.com/news/home/20251103631789/en/ The articles, information, and content displayed on this webpage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results